Advertisement

The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol

New Treatments For Hiv

Here's a taste of what TheBody.com has to offer on this topic:
Ask the Experts

gene therapy via blood stem cells new treatment for hiv ???

Hi Dr Bob,l am recently infected with hiv and guess what you have become my hero, please keep up the great work you do for us hivers around the world,l read all your posts and you are the man period...l need to start treatment asap cd4 300 and...
Robert J. Frascino, M.D.

Response from Robert J. Frascino, M.D.

The Robert James Frascino AIDS Foundation
Hello Pat,Thanks for your kind comments.The results of the OZ1 stem cell gene therapy phase II clinical trial were exciting and encouraging in equal measure. Dr. Ron Mitsuyasu at UCLA is an excellent HIV/AIDS/oncologist physician specialist who has... Read more »

New HIV Treatment?

My friends tell me HIV drugs are toxic and that I shouldn't take them. I have been told to go... Read more »

new way treatment cure for HIV

AUSTRALIAN scientists have revealed the most complete picture yet of the way HIV maintains its grip... Read more »
Articles
Henry J. Kaiser Family Foundation

New HIV Treatment Strategy Could Reduce HIV-Related Deaths by 10 Million in 15 Years, UNAIDS Says

UNAIDS on Tuesday outlined a new strategy, called "Treatment 2.0," to simplify the provision of HIV treatment and improve global access to antiretrovirals (ARVs), Reuters reports. The agency says the plan could prevent up to 10 million AIDS-related... Read more »
U.S. Food and Drug Administration

Approval of Edurant (Rilpivirine), a New NNRTI, for the Treatment of HIV in Treatment-Naive Patients

On Friday, May 20, 2011, FDA approved Edurant (rilpivirine) 25 mg tablets, a new non-nucleoside reverse transcriptase inhibitor (NNRTI) for the treatment of HIV. Rilpivirine is an antiviral drug that helps to block reverse transcriptase, an enzyme... Read more »
U.S. National Institute of Allergy and Infectious Diseases

Monitoring Board Recommends Stopping Experimental Treatment Regimen in International Study of Patients New to HIV Treatment

An independent Data and Safety Monitoring Board (DSMB) has determined that the experimental, once-daily antiretroviral drug regimen of emtricitabine, atazanavir and didanosine enteric-coated (ddI-EC) is inferior to a standard antiretroviral drug... Read more »
Henry J. Kaiser Family Foundation

Study Shows Nevirapine a New Treatment Option for HIV-Positive Infants

A new study shows that HIV-positive babies with stabilized infections "will do just fine switching to a regime of nevirapine, a reverse transcriptase inhibitor," from a more expensive protease inhibitor, Scientific American's "Observations " blog... Read more »
Connect With Others

New treatment approach to HIV: trial announcement

Posted by Anonymous
We've applied for patent protection on a novel treatment approach to HIV using existing medications already FDA-approved for other disease indications. We hope our approach will decrease infectivity by HIV virus, as well as delay progression to... Read more »

new hope for possibility of HIV treatment

Posted by lalamma, 3 Replies
This new treatment proposes to successfully control the virus in those infected, destroying a constant region of the virus and thus inactivating it's activity. The treatment may also prevent infection in high risk groups. This has been all over... Read more »

NEW HIV/AIDS TREATMENT

Posted by MICA_INC, 2 Replies
SEEKING CLINICAL TRIALS SPONSORSHIP & VOLUNTEERS

We are trying to get HIV Groups & Organizations, Medical and Pharmaceutical Institutions, and Universities and the Medical & Scientific Communities aware, informed and interested in MM-1,...
Read more »

NEW HIV/AIDS TREATMENT

Posted by MICA_INC
SEEKING CLINICAL TRIALS SPONSORSHIP & VOLUNTEERS

We are trying to get HIV Groups & Organizations, Medical and Pharmaceutical Institutions, and Universities and the Medical & Scientific Communities aware, informed and interested in MM-1,...
Read more »

Advertisement